Amedeo Smart

Free Medical Literature Service

 

Amedeo

Nuclear Medicine
  Free Subscription

Articles published in
Semin Nucl Med
    July 2026
  1. BOUCHELOUCHE K, Sathekge MM
    Expanding Horizons: The Role of Kaleidoscope and Relevant Images in Seminars in Nuclear Medicine.
    Semin Nucl Med. 2026;56:567-568.
    >> Share

    June 2026
  2. THOSTRUP AH, Stubbe NU, Schreiner MP, Bentestuen M, et al
    The diagnostic performance and clinical value of [18F]FDG PET/CT in pleural mesothelioma - A systematic review and meta-analysis.
    Semin Nucl Med. 2026 Jun 10:S0001-2998(26)00121.
    >> Share

  3. SADEGHPOUR S, Saidi B, Sahafi P, Maleki F, et al
    Maximizing diagnostic yield: A systematic review and deep dive into PSMA PET scan protocol variations for prostate cancer.
    Semin Nucl Med. 2026 Jun 2:S0001-2998(26)00112.
    >> Share

  4. SOVANI B, Ravindra SG, Javidan C, Dehdashti F, et al
    (18)F-FDG -PET/CT in cardiac sarcoidosis: Diagnosis, therapy monitoring, and future directions.
    Semin Nucl Med. 2026 Jun 1:S0001-2998(26)00113.
    >> Share

    May 2026
  5. AL-MALLAH MH
    The role of cardiac PET imaging in cardiac amyloidosis.
    Semin Nucl Med. 2026 May 30:S0001-2998(26)00118.
    >> Share

  6. ROY A, Abikhzer G, Slart RHJA, Alberini JL, et al
    PET imaging of large-vessel vasculitis: advancements and future trends.
    Semin Nucl Med. 2026 May 26:S0001-2998(26)00094.
    >> Share

  7. WOPPERER SB, Kronzer E, Ivare J, Taheri M, et al
    FDG PET for cardiac sarcoidosis: Protocol optimization, quantification, pitfalls, and multimodality imaging integration.
    Semin Nucl Med. 2026 May 21:S0001-2998(26)00093.
    >> Share

  8. HAMMOUD DA
    Imaging of immunocompromised patients: focus on fungal-specific PET tracers.
    Semin Nucl Med. 2026 May 18:S0001-2998(26)00095.
    >> Share

  9. DIAS AH, Fosbol MO, Ivashchenko OV, Andersen FL, et al
    Positron emission tomography imaging of inflammation and infection in children: an update.
    Semin Nucl Med. 2026 May 6:S0001-2998(26)00091.
    >> Share

  10. LAWAL IO, Ankrah AO, Abubakar S, Ndlovu H, et al
    Updates on tuberculosis imaging.
    Semin Nucl Med. 2026;56:486-499.
    >> Share

    April 2026
  11. BUND S, Stahle M, Massalha S, Wechalekar K, et al
    Advancements in PET imaging of inflammatory cardiac diseases.
    Semin Nucl Med. 2026 Apr 30:S0001-2998(26)00090.
    >> Share

  12. LAURI C, Aarntzen E, Glaudemans AW, Levi J, et al
    Radiopharmaceuticals for imaging T-cells.
    Semin Nucl Med. 2026 Apr 27:S0001-2998(26)00050.
    >> Share

  13. JENABI E, Hotta M, Atzinger A, Volkmann E, et al
    The Role of FAPI PET/CT in the Assessment of Inflammatory Diseases.
    Semin Nucl Med. 2026 Apr 22:S0001-2998(26)00085.
    >> Share

  14. ARNON-SHELEG E, Keidar Z
    Optimizing PET/CT and SPECT/CT in infection imaging: Acquisition, interpretation, and pitfalls.
    Semin Nucl Med. 2026 Apr 21:S0001-2998(26)00079.
    >> Share

  15. MARTINAGE N, Ledoult E, Baillet C, Huglo D, et al
    [(18)F]FDG PET/CT imaging in Polyarteritis Nodosa-spectrum vasculitis.
    Semin Nucl Med. 2026 Apr 20:S0001-2998(26)00086.
    >> Share

  16. TREGLIA G, Rizzo A, Albano D
    New targets for PET imaging of inflammation.
    Semin Nucl Med. 2026 Apr 20:S0001-2998(26)00084.
    >> Share

  17. ANKRAH AO, Lawal IIO, Ndlovu H, Sathekge MM, et al
    Current status on imaging invasive fungal infections with positron emission tomography.
    Semin Nucl Med. 2026 Apr 18:S0001-2998(26)00087.
    >> Share

  18. BULTEN BF, Slart RHJA, Glaudemans AWJM, Hess S, et al
    Standardization of infection [(18)F]FDG-PET/CT imaging protocols and reporting criteria.
    Semin Nucl Med. 2026 Apr 11:S0001-2998(26)00081.
    >> Share

  19. OZTEK MA, Shulkin BL, Parisi MT
    Pediatric infection imaging focusing on FDG PET/CT: Techniques, safety, and indications.
    Semin Nucl Med. 2026 Apr 8:S0001-2998(26)00082.
    >> Share

  20. LIU B, Hendrikse E, van der Geest KSM, Brouwer E, et al
    PET imaging of polymyalgia rheumatica: update and future trends.
    Semin Nucl Med. 2026 Apr 7:S0001-2998(26)00077.
    >> Share

  21. ALBANO D, Urso L, Treglia G, Bertagna F, et al
    The value of [(18)F]FDG PET/CT in fever of unknown origin (FUO): an update and future aspects.
    Semin Nucl Med. 2026 Apr 6:S0001-2998(26)00076.
    >> Share

  22. DONNELLY R, Boyle N, McCarthy C, Murphy DJ, et al
    FDG PET in pulmonary sarcoidosis: An update and future aspects.
    Semin Nucl Med. 2026 Apr 4:S0001-2998(26)00075.
    >> Share

  23. JAMAR F, van der Heijden WRP, van der Laken CJ, Beha N, et al
    PET/CT in inflammatory joint disorders: update and future trends.
    Semin Nucl Med. 2026 Apr 3:S0001-2998(26)00078.
    >> Share

    March 2026
  24. GATON-RAMIREZ J, Slart RHJA, Gheysens O, Noriega-Alvarez E, et al
    The evolving role of nuclear medicine in osteomyelitis: A narrative review of current evidence and future horizons.
    Semin Nucl Med. 2026 Mar 30:S0001-2998(26)00062.
    >> Share

  25. ORUNMUYI AT, Wang M, Rogeau A, Dickson J, et al
    Structured reading for Tau PET Imaging in Alzheimer's disease and related dementias.
    Semin Nucl Med. 2026 Mar 26:S0001-2998(26)00047.
    >> Share

  26. BADARNA M, Andraous M, Keidar Z
    18F-FDG PET/CT in the evaluation of suspected infections following cardiothoracic surgical interventions.
    Semin Nucl Med. 2026 Mar 26:S0001-2998(26)00065.
    >> Share

  27. GATON-RAMIREZ J, Noriega-Alvarez E
    The role of nuclear medicine in abdominopelvic infections.
    Semin Nucl Med. 2026 Mar 26:S0001-2998(26)00064.
    >> Share

  28. CURRIE GM, Bailey DL
    Quantification, radiomics and artificial intelligence in infection imaging: Current status and future directions in nuclear medicine.
    Semin Nucl Med. 2026 Mar 12:S0001-2998(26)00044.
    >> Share

  29. CURRIE GM
    Re-defining the 3Rs of pre-clinical research in nuclear medicine.
    Semin Nucl Med. 2026 Mar 12:S0001-2998(26)00043.
    >> Share

  30. MENA E, Lindenberg L, Heng S, Choyke PL, et al
    Advances and challenges of PET imaging in bladder cancer-An update and future trends.
    Semin Nucl Med. 2026 Mar 2:S0001-2998(26)00046.
    >> Share

  31. VALI R, Shammas A, Kwatra N, Haghparast EJ, et al
    Practical approach to diuretic renography in children: Techniques, interpretation, and pitfalls.
    Semin Nucl Med. 2026;56:258-277.
    >> Share

  32. ZUCKIER LS
    Scintigraphy as an ancillary examination in determination of death by neurologic criteria: Update and future perspectives.
    Semin Nucl Med. 2026;56:354-363.
    >> Share

  33. BRINK A, Bar-Sever Z, Orellana P, Pascual TN, et al
    Insights into the Global Practice of Paediatric Renal Scintigraphy Studies.
    Semin Nucl Med. 2026;56:235-243.
    >> Share

  34. PETERS AM
    Renography: Methods and Pitfalls.
    Semin Nucl Med. 2026;56:244-257.
    >> Share

  35. CURRIE GM, Rohren EM
    The Nuclear Nephrology Artificial Intelligence Ecosystem.
    Semin Nucl Med. 2026;56:313-328.
    >> Share

  36. VOLKAN-SALANCI B
    Renal Scintigraphy in Adults: An Update.
    Semin Nucl Med. 2026;56:278-288.
    >> Share

    February 2026
  37. MOKOALA KMG, Kaoma C, Jibril F, Kabunda J, et al
    Imaging of infection in Nephro-urology: A practical nuclear medicine-focused review.
    Semin Nucl Med. 2026 Feb 27:S0001-2998(26)00011.
    >> Share

  38. PANDYA K, Lazar A, Serrano LL, Amon MC, et al
    Can FAPI-PET imaging address unmet needs in nephro-urology?
    Semin Nucl Med. 2026 Feb 6:S0001-2998(26)00001.
    >> Share

    January 2026
  39. FUSO GA, Bianciardi G, Mei R, Brusa I, et al
    Retraction notice to Radiotracing the Future: Non-FDG Radiotracers Nuclear Medicine [Seminars Nucl Med 55 (2025) 648-663].
    Semin Nucl Med. 2026 Jan 16:S0001-2998(25)00185.
    >> Share

  40. VORSTER M, Sathekge M
    (18)F-FDG PET/CT for prediction of response in breast cancer.
    Semin Nucl Med. 2026 Jan 8:S0001-2998(25)00173.
    >> Share

  41. SEN I, Malik D, Thakral P
    Clinical implementation of RECIP 1.0.
    Semin Nucl Med. 2026;56:5-8.
    >> Share

  42. WIEFELS C, Juarez-Orozco LE, Craviolatti PS, Diahiliev O, et al
    Artificial intelligence in nuclear cardiology: Technical perspectives, strategic directions, and recommendations from an IAEA expert working group.
    Semin Nucl Med. 2026;56:119-131.
    >> Share

  43. AGGARWAL P, Satapathy S, Chandekar KR, Sood A, et al
    Response Evaluation Criteria in Grade 1/2 Neuroendocrine Tumors (RECIN).
    Semin Nucl Med. 2026;56:22-30.
    >> Share

    December 2025
  44. CIVAN C, Karpinski MJ, Rahbar K, Fendler WP, et al
    The value of PSMA PET for risk stratification in prostate cancer: an update and future aspects.
    Semin Nucl Med. 2025 Dec 25:S0001-2998(25)00181.
    >> Share

  45. SHAGERA QA, Ozturk AA, Pabst KM, Longton E, et al
    FAPI PET imaging value in radiotherapy planning and assessment in head and neck cancers.
    Semin Nucl Med. 2025 Dec 17:S0001-2998(25)00174.
    >> Share

  46. ARTESANI A, Olivieri M, Guglielmo P, Marenco M, et al
    PET-CT radiomics for immunotherapy response.
    Semin Nucl Med. 2025 Dec 13:S0001-2998(25)00176.
    >> Share

  47. BENTESTUEN M, Dahlsgaard-Wallenius S, Stolberg MMK, Zacho HD, et al
    Nonmalignant findings on FAPI PET: An updated rapid systematic review of the literature.
    Semin Nucl Med. 2025 Dec 8:S0001-2998(25)00168.
    >> Share

  48. SAFARIAN A, Muin D, Unterrainer L, Hormann A, et al
    The role of non-FDG agents in PET imaging of bladder cancer.
    Semin Nucl Med. 2025 Dec 8:S0001-2998(25)00165.
    >> Share

  49. RIZZO A, Treglia G
    PSMA PET in renal cell carcinoma: an update and future aspects.
    Semin Nucl Med. 2025 Dec 3:S0001-2998(25)00166.
    >> Share

  50. FILIPPI L, Mass ACL, Arslan E, Alcin G, et al
    Is There a Role of FAPI Pet in Renal and Bladder Cancer?
    Semin Nucl Med. 2025 Dec 1:S0001-2998(25)00157.
    >> Share

  51. KATAYEU Y, Grunwald V, Pabst KM, Yesilyurt UU, et al
    New targets of PET imaging for renal cancer.
    Semin Nucl Med. 2025 Dec 1:S0001-2998(25)00159.
    >> Share

    November 2025
  52. YANG R, Lu X, Tang W, Nardo L, et al
    Total-Body PET/CT Metabolic Response in Esophageal Squamous Cell Carcinoma.
    Semin Nucl Med. 2025 Nov 29:S0001-2998(25)00162.
    >> Share

  53. UENO Y, Nogami M, Hirota K, Hyodo T, et al
    Any Role of FDG PET in Renal Cancer?
    Semin Nucl Med. 2025 Nov 29:S0001-2998(25)00158.
    >> Share

  54. BADRANE I, Nieri A, Albano D, Arslan E, et al
    The Value of FDG PET/CT in Penile Cancer: An Update.
    Semin Nucl Med. 2025 Nov 29:S0001-2998(25)00160.
    >> Share

  55. XIE Y, Deng Y, Cruz EB, Pradhan PK, et al
    Clinical Utility of FAPI PET/CT in Diagnosis, Staging, and Response Assessment of Colorectal Cancer.
    Semin Nucl Med. 2025 Nov 28:S0001-2998(25)00163.
    >> Share

    October 2025
  56. HIGUCHI T, Chen X, Siegmund SC, Klimek K, et al
    Recent Advances and Future Trends of[(18)F]-Labeled PET Agents for Renal Imaging.
    Semin Nucl Med. 2025 Oct 15:S0001-2998(25)00124.
    >> Share

    September 2025
  57. KABUNDA J, Ndlovu H, Singh K, Sibiya S, et al
    Nectin-4, Bladder Cancer, and Nuclear Medicine: A Theranostic Frontier.
    Semin Nucl Med. 2025 Sep 26:S0001-2998(25)00118.
    >> Share

  58. THIENTUNYAKIT T, Muangpaisan W, Minoshima S
    Corrigendum to '18F-FDG PET for Dementia Evaluation: Co-pathologies, New Diseases, and Its Roles in The Era of Anti-Amyloid Treatment' [Seminar in Nuclear Medicine volume 55 (2025):526 -537/Article number YSNUC_51208].
    Semin Nucl Med. 2025 Sep 25:S0001-2998(25)00116.
    >> Share

    July 2025
  59. NYAKALE N, Maes A, Sathekge M, Li S, et al
    PSMA-Targeted Positron Emission Tomography Imaging in Solid Tumors Other Than Prostate Carcinoma: An Update.
    Semin Nucl Med. 2025 Jul 19:S0001-2998(25)00070.
    >> Share

  60. SAFARIAN A, Mirshahvalad SA, Farbod A, Jung T, et al
    Artificial Intelligence for Tumor [(18)F]FDG PET Imaging: Advancements and Future Trends - Part II.
    Semin Nucl Med. 2025 Jul 18:S0001-2998(25)00086.
    >> Share

  61. NOVRUZOV E, Mamlins E, Mori Y, Cardinale J, et al
    The Clinical Impact of FAPI PET Imaging: HCC, CCC, CUP & Peritoneal Carcinoma.
    Semin Nucl Med. 2025 Jul 18:S0001-2998(25)00090.
    >> Share

  62. FUSO GA, Bianciardi G, Mei R, Brusa I, et al
    Radiotracing the Future: Non-FDG Radiotracers Nuclear Medicine.
    Semin Nucl Med. 2025 Jul 16:S0001-2998(25)00069.
    >> Share

  63. PABST KM, Fendler WP, Jochheim LS, Herrmann K, et al
    The Value of FAPI PET/CT in Cholangiocarcinoma and Pancreatic Cancer: An Update.
    Semin Nucl Med. 2025 Jul 16:S0001-2998(25)00075.
    >> Share

  64. LIN W, Huang C, Tan Z, Xu H, et al
    Cu(II)-bis(thioureido) Complex: A Potential Radiotracer for Detecting Oxidative Stress and Neuroinflammation in Neurodegenerative Diseases.
    Semin Nucl Med. 2025;55:577-586.
    >> Share

  65. FILIPPI L, Schillaci O
    Global experience in brain amyloid imaging.
    Semin Nucl Med. 2025;55:538-547.
    >> Share

    June 2025
  66. FERRANDO R, Hernandes D, Ghini BG, Coutinho AM, et al
    PET Imaging in Psychiatric Disorders.
    Semin Nucl Med. 2025 Jun 20:S0001-2998(25)00068.
    >> Share

  67. RYU J, Oh M
    Positron Emission Tomography in Autism Spectrum Disorder: Current Status and Future Perspectives.
    Semin Nucl Med. 2025 Jun 12:S0001-2998(25)00065.
    >> Share

  68. STORMEZAND GN, Doorduin J, Glaudemans AWJM, van der Hoorn A, et al
    Current Developments on [(18)F]FDG PET/CT in Inflammatory Disorders of the Central Nervous System.
    Semin Nucl Med. 2025 Jun 11:S0001-2998(25)00066.
    >> Share

  69. YANG YJ, Zhao YX, Li XY, Zuo C, et al
    New Targets for Positron Emission Tomography Imaging in Parkinson s Disease.
    Semin Nucl Med. 2025 Jun 6:S0001-2998(25)00061.
    >> Share

  70. DELGADO BOLTON RC, Calapaqui Teran AK, Santiago Almeida L, Paez D, et al
    Fibroblast Activation Protein Inhibitor (FAPI) PET in Sarcoma: An Update and Future Perspective.
    Semin Nucl Med. 2025 Jun 1:S0001-2998(25)00060.
    >> Share

    May 2025
  71. MENA E, Lindenberg L, Herscovitch P, Sadowski SM, et al
    Advances in Endocrine Tumor PET Imaging Targeting CXCR4 and GLP-1.
    Semin Nucl Med. 2025 May 29:S0001-2998(25)00058.
    >> Share

  72. THIENTUNYAKIT T, Muangpaisan W, Minoshima S
    (18)F-FDG PET for Dementia Evaluation: Co-pathologies, New Diseases, and Its Roles in the Era of Antiamyloid Treatment.
    Semin Nucl Med. 2025 May 29:S0001-2998(25)00057.
    >> Share

  73. BENDER D
    New Radiopharmaceutical Tools in Imaging.
    Semin Nucl Med. 2025 May 26:S0001-2998(25)00059.
    >> Share

  74. BARANSKA K, Niemas K, Pelka K, Kunikowska J, et al
    PET/CT in the Imaging of CNS Tumors.
    Semin Nucl Med. 2025 May 21:S0001-2998(25)00040.
    >> Share

  75. LIN Z, Rasinski P, Nilsson T, Holstensson M, et al
    FAPI PET Versus FDG PET/CT in Gastrointestinal Cancers: An Overview.
    Semin Nucl Med. 2025 May 20:S0001-2998(25)00056.
    >> Share

  76. BRINK A, Paez D, Estrada Lobato E, Delgado Bolton RC, et al
    New Targets for Imaging in Nuclear Medicine.
    Semin Nucl Med. 2025 May 6:S0001-2998(25)00039.
    >> Share

  77. NERATTINI M, Abenavoli EM, Berti V
    PET/CT in Movement Disorders: Update.
    Semin Nucl Med. 2025 May 3:S0001-2998(25)00036.
    >> Share

  78. CAIRNS J, Frood R, Patel C, Scarsbrook A, et al
    The Role of AI in Lymphoma: An Update.
    Semin Nucl Med. 2025;55:377-386.
    >> Share

  79. EJAZ A, Naqvi AH, Perumalla HS, Bateman TM, et al
    Assessment of Myocardial Perfusion in Patients After CABG: An Update and Clinical Implications.
    Semin Nucl Med. 2025;55:460-469.
    >> Share

    April 2025
  80. SPOHN SKB, Grosu AL
    Impact of PSMA PET on Radiation Oncology Planning.
    Semin Nucl Med. 2025 Apr 22:S0001-2998(25)00034.
    >> Share

  81. VANDERLINDEN G, Vandenberghe R, Vandenbulcke M, Van Laere K, et al
    The Current Role of Tau PET Imaging in Neurodegeneration.
    Semin Nucl Med. 2025 Apr 21:S0001-2998(25)00031.
    >> Share

  82. YANG F, Lei B, Zhou Z, Song TA, et al
    AI in SPECT Imaging: Opportunities and Challenges.
    Semin Nucl Med. 2025 Apr 3:S0001-2998(25)00033.
    >> Share

    March 2025
  83. SAFARIAN A, Mirshahvalad SA, Farbod A, Nasrollahi H, et al
    Artificial intelligence for tumor [(18)F]FDG-PET imaging: Advancement and future trends-part I.
    Semin Nucl Med. 2025 Mar 29:S0001-2998(25)00032.
    >> Share

  84. KIRIENKO M, Cavinato L, Sollini M
    Infection and Inflammation in Nuclear Medicine Imaging: The Role of Artificial Intelligence.
    Semin Nucl Med. 2025 Mar 21:S0001-2998(25)00021.
    >> Share

  85. RICHLITZKI C, Manapov F, Holzgreve A, Rabe M, et al
    Advances of PET/CT in Target Delineation of Lung Cancer Before Radiation Therapy.
    Semin Nucl Med. 2025 Mar 9:S0001-2998(25)00022.
    >> Share

  86. CANGUT B, Akinlusi R, Mohseny A, Ghesani N, et al
    Evolving Paradigms in Lung Cancer: Latest Trends in Diagnosis, Management, and Radiopharmaceuticals.
    Semin Nucl Med. 2025 Mar 6:S0001-2998(25)00013.
    >> Share

  87. MIKKELSEN AFS, Thygesen J, Fledelius J
    Optimizing CT Imaging Parameters: Implications for Diagnostic Accuracy in Nuclear Medicine.
    Semin Nucl Med. 2025 Mar 6:S0001-2998(25)00015.
    >> Share

  88. SAFARIAN A, Mirshahvalad SA, Nasrollahi H, Jung T, et al
    Impact of [(18)F]FDG PET/CT Radiomics and Artificial Intelligence in Clinical Decision Making in Lung Cancer: Its Current Role.
    Semin Nucl Med. 2025 Mar 5:S0001-2998(25)00014.
    >> Share

  89. ALORFI F, Bomanji J, Bertoletti L, Fraioli F, et al
    PET/MRI in Non-Small Cell Lung Cancer (NSCLC).
    Semin Nucl Med. 2025 Mar 5:S0001-2998(25)00019.
    >> Share

  90. DELEU AL, Shagera QA, Veldhuijzen van Zanten S, Flamen P, et al
    FAPI PET in the Management of Lung Tumors.
    Semin Nucl Med. 2025 Mar 3:S0001-2998(25)00018.
    >> Share

    February 2025
  91. SATHEKGE C, Maes J, Maes A, Van de Wiele C, et al
    FDG PET/CT for Staging Lung Carcinoma: An Update.
    Semin Nucl Med. 2025 Feb 28:S0001-2998(25)00003.
    >> Share

  92. AYENI A, Evbuomwan O, Vangu MW
    The Role of [(18)F]FDG PET/CT in Monitoring of Therapy Response in Lung Cancer.
    Semin Nucl Med. 2025 Feb 27:S0001-2998(25)00010.
    >> Share

  93. BADARNA M, Keidar Z, Arnon-Sheleg E
    Current and Future Perspective of PET/CT in Response Assessment of Malignant Pleural Mesothelioma.
    Semin Nucl Med. 2025 Feb 27:S0001-2998(25)00009.
    >> Share

  94. VINJAMURI S, Pant V
    Demystifying the Role of Immuno PET-CT in Non-Small Cell Lung Cancer: Clinical Value and Research Trends.
    Semin Nucl Med. 2025 Feb 26:S0001-2998(25)00011.
    >> Share

  95. CURRIE GM, Rohren EM
    Potential of Technetium and Rhenium Theranostics.
    Semin Nucl Med. 2025 Feb 24:S0001-2998(25)00006.
    >> Share

  96. LOPES L, Lopez-Montes A, Chen Y, Koller P, et al
    The Evolution of Artificial Intelligence in Nuclear Medicine.
    Semin Nucl Med. 2025 Feb 10:S0001-2998(25)00005.
    >> Share

    January 2025
  97. LIU J, Sandhu K, Woon DTS, Perera M, et al
    The Value of Artificial Intelligence in Prostate-Specific Membrane Antigen Positron Emission Tomography: An Update.
    Semin Nucl Med. 2025 Jan 31:S0001-2998(24)00120.
    >> Share

  98. MOHSENINIA N, Eisazadeh R, Mirshahvalad SA, Zamani-Siahkali N, et al
    Diagnostic Value of Gastrin-Releasing Peptide Receptor-Targeted PET Imaging in Oncology: A Systematic Review.
    Semin Nucl Med. 2025 Jan 23:S0001-2998(25)00001.
    >> Share

    December 2024
  99. SACHPEKIDIS C, Goldschmidt H, Edenbrandt L, Dimitrakopoulou-Strauss A, et al
    Radiomics and Artificial Intelligence Landscape for [(18)F]FDG PET/CT in Multiple Myeloma.
    Semin Nucl Med. 2024 Dec 13:S0001-2998(24)00111.
    >> Share

    November 2024
  100. RATHOD N, Jutidamrongphan W, Bosbach WA, Chen Y, et al
    Total Body PET/CT: Clinical Value and Future Aspects of Quantification in Static and Dynamic Imaging.
    Semin Nucl Med. 2024 Nov 29:S0001-2998(24)00110.
    >> Share

  101. ZOGHI S, Mingels C, Badawi RD, Spencer BA, et al
    Role of Total Body PET/CT in Inflammatory Disorders.
    Semin Nucl Med. 2024 Nov 21:S0001-2998(24)00107.
    >> Share

  102. HAWK KE, Currie GM
    Artificial Intelligence and Workforce Diversity in Nuclear Medicine.
    Semin Nucl Med. 2024 Nov 19:S0001-2998(24)00090.
    >> Share

  103. GERKE O, Naghavi-Behzad M, Nygaard ST, Sigaroudi VR, et al
    Diagnosing Bone Metastases in Breast Cancer: A Systematic Review and Network Meta-Analysis on Diagnostic Test Accuracy Studies of 2-[(18)F]FDG-PET/CT, (18)F-NaF-PET/CT, MRI, Contrast-Enhanced CT, and Bone Scintigraphy.
    Semin Nucl Med. 2024 Nov 14:S0001-2998(24)00093.
    >> Share

  104. DIAS AH, Andersen KF, Fosbol MO, Gormsen LC, et al
    Long Axial Field-of-View PET/CT: New Opportunities for Pediatric Imaging.
    Semin Nucl Med. 2024 Nov 13:S0001-2998(24)00092.
    >> Share

  105. GODINEZ F, Mingels C, Bayerlein R, Mehadji B, et al
    Total Body PET/CT: Future Aspects.
    Semin Nucl Med. 2024 Nov 13:S0001-2998(24)00096.
    >> Share

  106. MARTINEZ-LUCIO TS, Mendoza-Ibanez OI, Liu W, Mostafapour S, et al
    Long Axial Field of View PET/CT: Technical Aspects in Cardiovascular Diseases.
    Semin Nucl Med. 2024 Nov 12:S0001-2998(24)00094.
    >> Share

  107. YANG N, Guo XY, Ding J, Wang F, et al
    Copper-64 Based PET-Radiopharmaceuticals: Ways to Clinical Translational.
    Semin Nucl Med. 2024 Nov 8:S0001-2998(24)00086.
    >> Share

  108. NANNI C, Farolfi A, Castellucci P, Fanti S, et al
    Total Body Positron Emission Tomography/Computed Tomography: Current Status in Oncology.
    Semin Nucl Med. 2024 Nov 7:S0001-2998(24)00091.
    >> Share

  109. DEV ID, Puranik AD, Singh B, Prasad V, et al
    Current and Future Perspectives of PDL1 PET and SPECT Imaging.
    Semin Nucl Med. 2024 Nov 6:S0001-2998(24)00084.
    >> Share

  110. LIN Y, Gao H, Zheng J, Al-Ibraheem A, et al
    Clinical Explorations of [(68)Ga] Ga-FAPI-04 and [(18)F] FDG Dual-Tracer Total-body PET/CT and PET/MR Imaging.
    Semin Nucl Med. 2024 Nov 2:S0001-2998(24)00085.
    >> Share

  111. MENA E, Lindenberg L, Choyke PL
    Update on PSMA-based Prostate Cancer Imaging.
    Semin Nucl Med. 2024;54:941-950.
    >> Share

  112. O'BRIEN SR, Edmonds CE, Ward RE, Taunk NK, et al
    Update on (18)F-Fluoroestradiol.
    Semin Nucl Med. 2024;54:812-826.
    >> Share

    October 2024
  113. CUMBERS GA, Harvey-Latham ED, Kassiou M, Werry EL, et al
    Emerging TSPO-PET Radiotracers for Imaging Neuroinflammation: A Critical Analysis.
    Semin Nucl Med. 2024 Oct 29:S0001-2998(24)00082.
    >> Share

  114. DUVENHAGE J, Kahts M, Summers B, Zeevaart JR, et al
    Highlighting New Research Trends on Zirconium-89 Radiopharmaceuticals Beyond Antibodies.
    Semin Nucl Med. 2024 Oct 26:S0001-2998(24)00088.
    >> Share

  115. NOGUEIRA-LIMA E, Alves T, Etchebehere E
    (18)F-Fluoride PET/CT-Updates.
    Semin Nucl Med. 2024 Oct 10:S0001-2998(24)00083.
    >> Share

  116. MENG X, Kong X, Wu R, Yang Z, et al
    Total Body PET/CT: A Role in Drug Development?
    Semin Nucl Med. 2024 Oct 9:S0001-2998(24)00081.
    >> Share

  117. STORMEZAND GN, de Meyer E, Koopmans KP, Brouwers AH, et al
    Update on the Role of [(18)F]FDOPA PET/CT.
    Semin Nucl Med. 2024 Oct 8:S0001-2998(24)00080.
    >> Share

  118. AL-IBRAHEEM A, Abdlkadir AS, Shi H, Abdel-Razeq H, et al
    PET/CT Assessment of Estrogen Receptor positivity for Breast Cancer using [(68)Ga]Ga-RM2 Bombesin Receptor Antagonist: A Systematic Review and Meta-Analysis.
    Semin Nucl Med. 2024 Oct 5:S0001-2998(24)00079.
    >> Share

  119. ZHANG Q, Huang Z, Jin Y, Li W, et al
    Total-Body PET/CT: A Role of Artificial Intelligence?
    Semin Nucl Med. 2024 Oct 4:S0001-2998(24)00078.
    >> Share

    September 2024
  120. MINGELS C, Chung KJ, Pantel AR, Rominger A, et al
    Total-Body PET/CT: Challenges and Opportunities.
    Semin Nucl Med. 2024 Sep 27:S0001-2998(24)00076.
    >> Share

  121. NOSKOVICOVA L, Balogova S, Aveline C, Tassart M, et al
    (18)F-Fluorocholine-Positron Emission Tomography/Computerized Tomography (FCH PET/CT) Imaging for Detecting Abnormal Parathyroid Glands: Indication, Practice, Interpretation and Diagnostic Performance.
    Semin Nucl Med. 2024 Sep 20:S0001-2998(24)00075.
    >> Share

  122. HICKS RJ, Ware RE, Callahan J
    Total-Body PET/CT: Pros and Cons.
    Semin Nucl Med. 2024 Sep 16:S0001-2998(24)00065.
    >> Share

  123. NAYFEH M, Sayed A, Alwan M, Alfawara M, et al
    Hybrid Imaging: Calcium Score and Myocardial Perfusion Imaging.
    Semin Nucl Med. 2024;54:638-647.
    >> Share

  124. CLERC OF, Vijayakumar S, Dorbala S
    Radionuclide Imaging of Cardiac Amyloidosis: An Update and Future Aspects.
    Semin Nucl Med. 2024;54:717-732.
    >> Share

  125. MILLER RJH, Slomka PJ
    Artificial Intelligence in Nuclear Cardiology: An Update and Future Trends.
    Semin Nucl Med. 2024;54:648-657.
    >> Share

    August 2024
  126. COURAULT P, Zimmer L, Lancelot S
    Toward Functional PET Imaging of the Spinal Cord.
    Semin Nucl Med. 2024 Aug 23:S0001-2998(24)00066.
    >> Share

    July 2024
  127. WAHL RL, Kahl B
    The Rebirth of Radioimmunotherapy of Non-Hodgkin Lymphoma: The Phoenix of Nuclear Medicine?
    Semin Nucl Med. 2024 Jul 16:S0001-2998(24)00055.
    >> Share

  128. KLEYNHANS J, Ebenhan T, Sathekge MM
    Expanding Role for Gallium-68 PET Imaging in Oncology.
    Semin Nucl Med. 2024 Jul 3:S0001-2998(24)00054.
    >> Share

  129. SATHEKGE MM, Bouchelouche K
    Letter from the Editors.
    Semin Nucl Med. 2024;54:457-459.
    >> Share

    June 2024
  130. KATAL S, Patel P, Lee J, Taubman K, et al
    Total Body PET/CT: A Role in Musculoskeletal Diseases.
    Semin Nucl Med. 2024 Jun 28:S0001-2998(24)00049.
    >> Share

  131. MAHAJAN S, Gavane S, Pandit-Taskar N
    Targeted Radiopharmaceutical Therapy for Bone Metastases.
    Semin Nucl Med. 2024 Jun 26:S0001-2998(24)00047.
    >> Share

  132. DULLEA A, O'Sullivan L, O'Brien KK, Carrigan M, et al
    Diagnostic Accuracy of (18)F-Prostate Specific Membrane Antigen (PSMA) PET/CT Radiotracers in Staging and Restaging of Patients With High-Risk Prostate Cancer or Biochemical Recurrence: An Overview of Reviews.
    Semin Nucl Med. 2024 Jun 20:S0001-2998(24)00044.
    >> Share

  133. KAZIMIERCZYK R, Kaminski KA, Nekolla SG
    Cardiac PET/MRI: Recent Developments and Future Aspects.
    Semin Nucl Med. 2024 Jun 8:S0001-2998(24)00048.
    >> Share

  134. DIMITRAKOPOULOU-STRAUSS A, Pan L, Sachpekidis C
    Total Body PET-CT Protocols in Oncology.
    Semin Nucl Med. 2024 Jun 7:S0001-2998(24)00050.
    >> Share

  135. CURRIE GM, Hawk KE, Rohren EM
    Generative Artificial Intelligence Biases, Limitations and Risks in Nuclear Medicine: An Argument for Appropriate Use Framework and Recommendations.
    Semin Nucl Med. 2024 Jun 7:S0001-2998(24)00046.
    >> Share

  136. SACHPEKIDIS C, Dimitrakopoulou-Strauss A
    Long Axial Field-of-View (LAFOV) PET/CT in Prostate Cancer.
    Semin Nucl Med. 2024 Jun 1:S0001-2998(24)00045.
    >> Share

    May 2024
  137. BOUCHELOUCHE K, Sathekge MM
    Letter from the Editors.
    Semin Nucl Med. 2024;54:311-312.
    >> Share

  138. HABERL C, Crean AM, Zelt JGE, Redpath CJ, et al
    Role of Nuclear Imaging in Cardiac Stereotactic Body Radiotherapy for Ablation of Ventricular Tachycardia.
    Semin Nucl Med. 2024;54:427-437.
    >> Share

    April 2024
  139. PAEZ D, Giammarile F, Brink A, Garcia-Perez O, et al
    The Role of 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) in the Diagnosis and Evaluation of Spondylodiscitis.
    Semin Nucl Med. 2024 Apr 29:S0001-2998(24)00032.
    >> Share

  140. GUJA KE, Behr G, Bedmutha A, Kuhn M, et al
    Molecular Imaging with PET-CT and PET-MRI in Pediatric Musculoskeletal Diseases.
    Semin Nucl Med. 2024 Apr 29:S0001-2998(24)00030.
    >> Share

    March 2024
  141. VAN DER GEEST KSM, Gheysens O, Gormsen LC, Glaudemans AWJM, et al
    Advances in PET Imaging of Large Vessel Vasculitis: An Update and Future Trends.
    Semin Nucl Med. 2024 Mar 26:S0001-2998(24)00026.
    >> Share

  142. HIGUCHI T, Serfling SE, Leistner DM, Speer T, et al
    FAPI-PET in Cardiovascular Disease.
    Semin Nucl Med. 2024 Mar 21:S0001-2998(24)00023.
    >> Share

  143. GUJA KE, Ganjoo KN, Iagaru A
    Molecular Imaging in Soft-tissue Sarcoma: Evolving Role of FDG PET.
    Semin Nucl Med. 2024 Mar 2:S0001-2998(24)00012.
    >> Share

  144. EKMEKCIOGLU O, Albert NL, Heinrich K, Tolboom N, et al
    Neurological Disorders and Women's Health: Contribution of Molecular Neuroimaging Techniques.
    Semin Nucl Med. 2024;54:237-246.
    >> Share

  145. EVANGELISTA L, Israel O
    Letter From the Guest Editors.
    Semin Nucl Med. 2024;54:181-182.
    >> Share

  146. FILIPPI L, Camedda R, Frantellizzi V, Urbano N, et al
    Functional Imaging in Musculoskeletal Disorders in Menopause.
    Semin Nucl Med. 2024;54:206-218.
    >> Share

    February 2024
  147. KHALATBARI H, Shulkin BL, Parisi MT
    PET/CT and PET/MR in Soft Tissue Sarcoma: An Update.
    Semin Nucl Med. 2024 Feb 28:S0001-2998(24)00005.
    >> Share

  148. ULANER GA, Vaz SC
    Women's Health Update: Growing Role of PET for Patients with Breast Cancer.
    Semin Nucl Med. 2024 Feb 16:S0001-2998(24)00006.
    >> Share

  149. GIAMMARILE F, Knoll P, Paez D, Estrada Lobato E, et al
    Fibroblast Activation Protein Inhibitor (FAPI) PET Imaging in Sarcomas: A New Frontier in Nuclear Medicine.
    Semin Nucl Med. 2024 Feb 15:S0001-2998(24)00001.
    >> Share

  150. KHESSIB T, Jha P, Davidzon GA, Iagaru A, et al
    Nuclear Medicine and Molecular Imaging Applications in Gynecologic Malignancies: A Comprehensive Review.
    Semin Nucl Med. 2024 Feb 10:S0001-2998(24)00003.
    >> Share

  151. EISAZADEH R, Shahbazi-Akbari M, Mirshahvalad SA, Pirich C, et al
    Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [(18)F]F-FDG Tracers Part II. [(18)F]F-FLT, [(18)F]F-FET, [(11)C]C-MET and Other Less-Commonly Used Radiotracers.
    Semin Nucl Med. 2024 Feb 7:S0001-2998(24)00002.
    >> Share

    January 2024
  152. EVANGELISTA L, Guglielmo P, Pietrzak A, Lazar AM, et al
    The Future Direction of Women in Nuclear Medicine and Nuclear Medicine in Women's Health.
    Semin Nucl Med. 2024 Jan 12:S0001-2998(23)00105.
    >> Share

  153. ZAMANI-SIAHKALI N, Mirshahvalad SA, Farbod A, Divband G, et al
    SPECT/CT, PET/CT, and PET/MRI for Response Assessment of Bone Metastases.
    Semin Nucl Med. 2024 Jan 2:S0001-2998(23)00093.
    >> Share

    December 2023
  154. BENTESTUEN M, Nalliah S, Stolberg MMK, Zacho HD, et al
    How to Perform FAPI PET? An Expedited Systematic Review Providing a Recommendation for FAPI PET Imaging With Different FAPI Tracers.
    Semin Nucl Med. 2023 Dec 4:S0001-2998(23)00092.
    >> Share

  155. TELLI T, Desaulniers M, Pyka T, Caobelli F, et al
    What Role Does PET/MRI Play in Musculoskeletal Disorders?
    Semin Nucl Med. 2023 Dec 2:S0001-2998(23)00091.
    >> Share

    November 2023
  156. GHEYSENS O, de Ponfilly MP, Nocturne G, Seror R, et al
    [(18)F]FDG-PET/CT in Polymyalgia Rheumatica: An Update and Future Aspects.
    Semin Nucl Med. 2023 Nov 28:S0001-2998(23)00083.
    >> Share

  157. MOKOALA KMG, Ndlovu H, Lawal I, Sathekge MM, et al
    PET/CT and SPECT/CT for Infection in Joints and Bones: An Overview and Future Directions.
    Semin Nucl Med. 2023 Nov 27:S0001-2998(23)00087.
    >> Share

  158. BRINK A, Israel O, Nadel H, Arevalo-Pardo M, et al
    Towards a More Inclusive Future: A Comprehensive Assessment of Gender Diversity in Nuclear Medicine Education, Training and Workforce.
    Semin Nucl Med. 2023 Nov 18:S0001-2998(23)00086.
    >> Share

  159. VOTER AF, Werner RA, Savas H, Gafita A, et al
    A Practical Guide to the Pearls and Pitfalls of PSMA PET Imaging.
    Semin Nucl Med. 2023 Nov 16:S0001-2998(23)00088.
    >> Share

  160. BESSON FL, Nocturne G, Noel N, Gheysens O, et al
    PET/CT in Inflammatory and Auto-immune Disorders: Focus on Several Key Molecular Concepts, FDG, and Radiolabeled Probe Perspectives.
    Semin Nucl Med. 2023 Nov 14:S0001-2998(23)00084.
    >> Share

  161. CARACCIOLO M, Castello A, Lopci E
    PSMA PET/CT Versus mpMRI for the Detection of Clinically Significant Prostate Cancer: An Updated Overview.
    Semin Nucl Med. 2023 Nov 9:S0001-2998(23)00082.
    >> Share

  162. GIUBBINI R, Paghera B, Dondi M, Estrada Lobato E, et al
    Critical Appraisal of the Current Role of Myocardial Perfusion Imaging in the Management of Acute Chest Pain.
    Semin Nucl Med. 2023;53:733-742.
    >> Share

  163. LOW CS, Rao N
    Imaging of Gastrointestinal Bleeding: An Update.
    Semin Nucl Med. 2023;53:766-776.
    >> Share

  164. SIRAJ QH
    Functional Imaging of Testicular Torsion.
    Semin Nucl Med. 2023;53:797-808.
    >> Share

  165. LE ROUX PY, Le Pennec R, Salaun PY, Zuckier LS, et al
    Scintigraphic Diagnosis of Acute Pulmonary Embolism: From Basics to Best Practices.
    Semin Nucl Med. 2023;53:743-751.
    >> Share

  166. JABBARPOUR A, Ghassel S, Lang J, Leung E, et al
    The Past, Present, and Future Role of Artificial Intelligence in Ventilation/Perfusion Scintigraphy: A Systematic Review.
    Semin Nucl Med. 2023;53:752-765.
    >> Share

  167. LINDENBERG L, Ahlman M, Lin F, Mena E, et al
    Advances in PET Imaging of the CXCR4 Receptor: [(68)Ga]Ga-PentixaFor.
    Semin Nucl Med. 2023 Nov 1:S0001-2998(23)00080.
    >> Share

    September 2023
  168. MIRSHAHVALAD SA, Eisazadeh R, Shahbazi-Akbari M, Pirich C, et al
    Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [(18)F]F-FDG Tracers - Part I. PSMA, Choline, and DOTA Radiotracers.
    Semin Nucl Med. 2023 Sep 24:S0001-2998(23)00073.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016